Asthma. Asthma
Conditions
Interventions
Received conventional asthma therapy ,Received conventional asthma therapy and oral supplementation of oligo-fucoidan 2200 mg for 24 weeks
Conventional asthma therapy,Fucoidan
Sponsors
Hi-Q Marine Biotech International Ltd
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria were (1) presence of allergic asthma, (2) absence of complicated underlying disease, (3) lack of history of upper or lower airway disease during the month before the study, and (4) not having received immunotherapy or oral or intravenous steroids during the four weeks before the study (inhaled steroids were allowed).
Exclusion criteria
Exclusion criteria: The exclusion criteria were malignancy, infection, pregnancy, and other systemic immune diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oligo-fucoidan could inhibit inflammation after treatment 12 weeks and 24 weeks Analysis of the levels of cytokines,increase pulmonary function after treatment 12 weeks and 24 weeks asthma control test | — |
Secondary
| Measure | Time frame |
|---|---|
| increase pulmonary function after treatment 12 weeks and 24 weeks Lung function test | — |
Countries
Taiwan
Contacts
Public ContactYaling Chiou
Hungkuang University
Outcome results
None listed